NF/MNC injection at early time points post-MI decreases infarct size. by Ming-Yao Chang (700415)

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Increases and decreases in resources. by Guangliang Li (194029)

Stroma decreases spheroid size by decreasing cell width. by Karen F. Chambers (224337)

Decreased oocyte quality correlates with decreased oocyte size. by Sara Andux (268591)

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(L) Quantitative RT-PCR showing the expression level of several flow-responsive genes after lidocaine treatment. <i>klf2a</i> expression is significantly decreased after 6 and 10 h of treatment and is restored by incubation at 34°C; 100% of expression corresponds to a normal expression level. …”

PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points. by Jordan A. Gunning (18143970)

Subjects:

CLKGR expression decreases the amplitude of CLK-driven transcriptional oscillations. by Ron Weiss (22503)

Elevated PE level in yeast decreases the sensitivity of replicating tombusvirus RNA to the reconstituted RNAi. by Nikolay Kovalev (184967)

“…Note that AGO1 and DCR1 were continuously expressed during the entire yeast culturing process to enhance RNAi activities in both strains. See <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006520#ppat.1006520.g001" target="_blank">Fig 1A</a> for further details. …”

mTOR inhibition decreased mitochondrial mass. by Piero Dalle Pezze (622889)

“…Gradual mTOR specific inhibition from 0% (black, control) to 90% predicted a decrease in mitochondrial mass due to the perturbation of the population of old mitochondria. …”

Mitochondrial dysfunction is driven by decreased mitochondrial dynamics. by Piero Dalle Pezze (622889)

“…These perturbations affected the new mitochondria only at early time points (<10 days), whereas the old mitochondria were affected throughout the time course. …”

A randomized trial of a behavioral intervention to decrease hospital length of stay by decreasing bedrest by Juliana Tolles (8282265)

“…Previous studies of early mobilization have demonstrated improvement in outcomes, but the interventions studied have been resource-intensive. We aimed to decrease the time hospital inpatients spend in bed through a pragmatic mobilization protocol.…”

MRV decreases the post-therapy viral load set point. by Iart Luca Shytaj (157809)

Microsaccades decrease large and increase small blink-induced fixation errors. by Francisco M. Costela (647619)

“…[We note that, although we considered all blinks in our analyses, blinks that took the eye below the fixation point were relatively infrequent (∼18%). …”

Syntaxin-4 shRNA decreases spine number and structural plasticity by Michael Patterson (96521)

Effectiveness of interventions to decrease hesitancy. by Maximilian Nicolaus Burger (12969212)

Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

“…<b><i>Methods:</i></b> The levels of 17 potential biomarkers with an association with cardiovascular risk were quantitated in plasma from 37 age- and gender-matched psoriasis patients and controls at baseline and in 21 psoriasis patients after 12 weeks of NB-UVB treatment to identify a systemic treatment response. <b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

“…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. Activation of RhoA was quantified by RhoA G-LISA small G-protein assay. …”

Autophagy is decreased at later time points post-infection in human macrophages. by Grant R. Campbell (298586)

Higher reward decreases time-point variability dynamically throughout the trial. by Zvi N. Roth (9611598)